Globe Life (NYSE:GL – Get Free Report) issued an update on its FY25 earnings guidance on Wednesday morning. The company provided EPS guidance of $13.20-13.90 for the period, compared to the consensus EPS estimate of $13.25. Globe Life also updated its FY 2024 guidance to 12.200-12.400 EPS.
Globe Life Stock Down 3.9 %
GL stock opened at $105.15 on Friday. The company has a 50 day moving average of $105.37 and a two-hundred day moving average of $90.88. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.31. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00. The company has a market cap of $9.47 billion, a price-to-earnings ratio of 10.04 and a beta of 0.81.
Globe Life (NYSE:GL – Get Free Report) last issued its earnings results on Wednesday, October 23rd. The company reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.06 by $0.43. Globe Life had a return on equity of 21.93% and a net margin of 18.47%. The firm had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter in the previous year, the company posted $2.71 earnings per share. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, equities analysts anticipate that Globe Life will post 11.93 earnings per share for the current fiscal year.
Globe Life Announces Dividend
Analyst Ratings Changes
Several equities research analysts recently issued reports on GL shares. Morgan Stanley lifted their price objective on shares of Globe Life from $110.00 to $120.00 and gave the company an “equal weight” rating in a research note on Thursday. Jefferies Financial Group upped their price target on Globe Life from $85.00 to $88.00 and gave the stock a “hold” rating in a research note on Friday, June 28th. Truist Financial raised their price objective on Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research note on Friday. Raymond James upped their target price on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research report on Tuesday, October 15th. Finally, Piper Sandler upped their price objective on shares of Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a report on Friday. Five analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $123.80.
Check Out Our Latest Analysis on Globe Life
Globe Life Company Profile
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also
- Five stocks we like better than Globe Life
- Ride Out The Recession With These Dividend Kings
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- When to Sell a Stock for Profit or Loss
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Calculate Return on Investment (ROI)
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.